Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
US Department of Justice
Mallinckrodt
Express Scripts
Farmers Insurance
Healthtrust
Boehringer Ingelheim
Daiichi Sankyo

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,633,262

« Back to Dashboard

Summary for Patent: 5,633,262
Title: Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof
Abstract:The present invention relates to a novel quinolone compound having an excellent antibacterial activity. More specifically, the present invention relates to a novel quinoline(naphthyridine)carboxylic acid derivative represented by the following formula (I), which has an 4-aminomethyl-3-oximepyrrolidine substituent on 7-position of the quinolone nucleus and shows a superior antibacterial activity in contrast to the known quinolone antibacterial agents having a weak activity against gram-positive bacterial strains and also has a broad antibacterial spectrum and a highly improved pharmacokinetic property: ##STR1## wherein R, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and Q are defined as described in the specification.
Inventor(s): Hong; Chang Y. (Daejeon, KR), Kim; Young K. (Kyungki-do, KR), Chang; Jay H. (Daejeon, KR), Kim; Se H. (Seoul, KR), Choi; Hoon (Daejeon, KR), Nam; Do H. (Daejeon, KR), Kwak; Jin H. (Daejeon, KR), Jeong; Yi N. (Daejeon, KR), Oh; Jeong I. (Daejeon, KR), Kim; Mu Y. (Daejeon, KR)
Assignee: LG Chemical Ltd. (Seoul, KR)
Application Number:08/490,978
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form;

Drugs Protected by US Patent 5,633,262

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,633,262

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
South Korea94-13604Jun 16, 1994
South Korea94-39915Dec 30, 1994
South Korea94-39930Dec 30, 1994

International Family Members for US Patent 5,633,262

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1114959 ➤ Try a Free Trial
China 1058010 ➤ Try a Free Trial
Germany 69509442 ➤ Try a Free Trial
Denmark 0688772 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
McKinsey
Daiichi Sankyo
Covington
Federal Trade Commission
Fuji
Julphar
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.